Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Psychiatric Services (Washington, D.C.)|August 6, 2008
Medical services for clients in community mental health centers: results from a national surveyBenjamin G Druss, Steven C Marcus, Jeannie Campbell, et al.Journal of Substance Abuse Treatment|December 22, 2004
Treatment for substance use disorders in a privately insured population under managed care: costs and services useShelly F Greenfield, Vanessa Azzone, Haiden Huskamp, et al.Schizophrenia Research|December 25, 2008
Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorderLeslie Citrome, Christopher Reist, Liisa Palmer, et al.Schizophrenia Research|October 30, 2009
Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorderLeslie Citrome, Christopher Reist, Liisa Palmer, et al.Health Services Research|May 31, 2002
Mental health costs and access under alternative capitation systems in ColoradoJoan R Bloom, Teh-Wei Hu, Neal Wallace, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 7, 2018
Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)Loretta A Williams, Meagan S Whisenant, Tito R Mendoza, et al.European Neurology|April 26, 2008
Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: a systematic comparisonMark S Freedman, Bruce Hughes, Daniel D Mikol, et al.The Oncologist|March 24, 2023
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost CalculatorAlbrecht Stenzinger, Brian Cuffel, Noman Paracha, et al.Journal of Patient-Reported Outcomes|June 19, 2019
Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)Tito R Mendoza, Loretta A Williams, Karen N Keating, et al.Scientific Reports|June 27, 2024
Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesotheliomaCharles S Cleeland, Karen N Keating, Brian Cuffel, et al.Pageof 2